2156 J. Am. Chem. Soc., Vol. 122, No. 10, 2000
Wilk et al.
was distilled under reduced pressure to give the colorless phosphor-
dichloridite 6 (34.83 g, 0.13 mol, 87%). Bp: 91-94 °C/0.2 mmHg.
1H NMR (300 MHz, C6D6) δ 2.85 (m, 2H), 3.62 (m, 2H). 13C NMR
(M + Cs+) 902.1618, found 902.1644; Sp-1: calcd for C41H41FN3O9P
(M + Cs+) 902.1618, found 902.1643.
General Procedure for Manual Solid-Phase Synthesis of [RP, RP]-
and [SP, SP]-d(CPSCPSC), [RP, SP, RP]-d(CPSCPSCPSC), and [RP]11-
d[(TPS)11T]. [RP, RP]-CPSCPSC: A standard DMT-dCBz-LCAA-CPG
column (0.2 µmol) was subjected to the following sequence of steps:
1, 2, 3, 2, 3, 4, 1, 2, 3, 2, 3, 5. Step 1: 3% TCA (w/v)/CH2Cl2 (3 mL,
1 min), followed by washing with dry MeCN (3 mL, 30 s). Step 2:
Sp-1, (5 mg, ∼5 µmol) and TMG (4 µL, ∼30 µmol) in dry MeCN
(200 µL), 5 min, followed by washing with MeCN (3 mL, 30 s). Step
3: 0.05 M 3H-1,2-benzodithiol-3-one 1,1-dioxide in MeCN (200 µL),
3 min, followed by washing with MeCN (3 mL, 30 s). Step 4: Ac2O/
2,6-lutidine/THF (1 mL), mixed with 1-methylimidazole/THF (1 mL),
2 min, followed by washing with MeCN (3 mL, 30 s). Step 5:
Concentrated NH4OH (1 mL, 10 h, 55 °C). [SP, SP]-CPSCPSC: identical
to the preparation of [RP,RP]-CPSCPSC except that RP-1 was used in
step 2. [RP, SP, RP]-CPSCPSCPSC: A standard DMT-dCBz-LCAA-CPG
column (0.2 µmol) was subjected to the following sequence of steps:
1, 2, 3, 2, 3, 4, 1, 2′, 3, 2′, 3, 4, 1, 2, 3, 2, 3, 5. Steps were identical to
those used for the preparation of [RP,RP]-CPSCPSC except that RP-1 was
used in step 2′ which otherwise was identical to step 2. [RP]11-
d[(TPS)11T]: A column filled with DMT-T covalently attached to
LCAA-CPG (0.2 µmol) through a succinyl-sarcosyl linker36 was
subjected to the following sequence of steps: (1, 2, 3, 2, 3, 4)10, 1, 2,
3, 2, 3, 5. Steps were identical to those used for the preparation of
[RP,RP]-CPSCPSC except that SP-14 was used in step 2.
2
(75 MHz, C6D6) δ 39.3 (d, JCP ) 3.9 Hz), 65.5 (d, JCP ) 9.7 Hz),
1
2
116.2 (q, JCF ) 288 Hz), 157.3 (q, JCF ) 36.7 Hz). 31P NMR (121
MHz, C6D6) δ 178.1. EI-HRMS: calcd for C4H5Cl2F3NO2P (M+•
-
HCl) 220.9621, found 220.9634. Upon prolonged standing (2 y) at -20
°C, phosphordichloridite 6 cyclized to the chloro phosphine 7 ( ∼60%)
which was isolated by distillation as a mixture of rotamers 7a and 7b.
Bp: 33-35 °C/0.2 mmHg. 1H NMR (300 MHz, C6D6) δ 2.85 (m, 1H),
3.06 (m, 1H), 3.67 (m, 1H), 3.89 (m, 1H). 13C NMR (75 MHz, C6D6)
2
1
δ 41.7, 43.0, 68.7 (d, JCP ) 7.7 Hz), 72.4, 116.0 (q, JCF ) 288 Hz),
1
116.3 (q, JCF ) 288 Hz), 157.2 (q, JCF ) 36.7 Hz), 157.3 (q, JCF
)
36.7 Hz). 31P NMR (121 MHz, C6D6) δ 145.9 (q, JPF ) 74.2 Hz), 151.4.
19F NMR (282 MHz, C6D6) δ -74.4, -71.9 (d, JFP ) 75.0 Hz). EI-
HRMS: calcd for C4H4ClF3NO2P (M+•) 220.9621, found 220.9622.
N4-Benzoyl-5′-O-(4,4′-dimethoxytrityl)-3′-O-[3-(2-fluoroacetyl)-
5-phenyl-1,3,2-oxazaphospholanyl] -2′-deoxycytidine (RP-1 and SP-
1). To a solution of vacuum-dried 8 (1.90 g, 3.0 mmol) and
phosphinylating reagent 5 (980 mg, 3.3 mmol) in dry acetonitrile (15
mL) was added via syringe a 0.4 M solution of 1H-tetrazole in dry
acetonitrile (8.3 mL, 3.3 mmol). The reaction mixture was stirred at
room temperature (20 min) until only traces ( ∼1-2%) of unreacted 8
could be detected by HPTLC analysis. The reaction mixture was then
concentrated to a volume of ∼4 mL under reduced pressure, and applied
to the top of a silica gel (Merck 9385, 230-400 mesh, 60 Å, 45 g)
chromatography column (3.5 cm ID × 10 cm) equilibrated in CHCl3-
CH3CN (3:1). The column was eluted with a linear gradient of CHCl3-
CH3CN (3:1 v/v) to CHCl3-CH3CN (25:10) to afford pure SP-1 (300
mg, 0.35 mmol) and RP-1 (232 mg, 0.27 mmol) as white amorphous
solids. A mixture of RP-1 and SP-1 was also isolated (739 mg, 0.86
mmol).
Each ammoniacal solution collected from step 5 was concentrated
under reduced pressure, and the crude oligomer was purified “trityl
on” by RP-HPLC using a 5 µm Supelcosil LC-18S column (25 cm ×
4.6 mm) and a linear gradient of 1% MeCN/min, starting from 0.1 M
triethylammonium acetate pH 7.0, at a flow rate of 1 mL/min.
Appropriate fractions were pooled together, evaporated to dryness under
vacuum, and treated with aqueous 80% AcOH for 30 min. After
removal of excess acid under low pressure, the purified oligonucleotide
was dissolved in distilled water and further analyzed by RP-HPLC using
the same column and chromatographic conditions as those employed
for the purification of the crude oligonucleotide. RP-HPLC chromato-
gram of [RP, SP, RP]-CPSCPSCPSC is shown in Figure 3, whereas
chromatograms of [RP, RP]-CPSCPSC and [SP, SP]-CPSCPSC are
displayed as Supporting Information. In the case of unpurified [RP]11-
d[(TPS)11T], the “trityl on” RP-HPLC chromatogram and a photograph
of its “trityl off” PAGE profile are shown as Supporting Information.
An alternate route to the preparation of RP-1 and SP-1 relied on the
addition of anhydrous acetonitrile (5 mL) to vacuum-dried 8 (1.00 g,
1.58 mmol) and 1H-tetrazole (111 mg, 1.58 mmol). To the stirred
solution was added phosphoramidite 5 (520 mg, 1.75 mmol), dropwise
by syringe, over 15 min. Thin-layer chromatography was used to
monitor the reaction to completion. The reaction mixture was evaporated
to a foam under reduced pressure. Ethyl acetate (3 mL) was added to
the foamy residue, and the resulting suspension was applied to a short
silica gel (Merck 9385, 230-400 mesh, 60 Å, 67 g) chromatography
column (9.0 cm ID × 2 cm) equilibrated in EtOAc. The flask containing
crude RP-1 and SP-1 was rinsed with fresh EtOAc (2 mL), which was
added to the top of the column after the first EtOAc layer had dispersed
through the column. Further elution with EtOAc gave SP-1 (302 mg,
0.35 mmol) and RP-1 (359 mg, 0.42 mmol) as white foamy solids. As
above, a mixture of RP-1 and SP-1 was also isolated (198 mg, 0.23
mmol). HPTLC-RP2F (Analtech): RP-1, Rf (CHCl3:CH3CN 2:1 v/v)
) 0.51; SP-1, Rf (CHCl3:CH3CN 2:1 v/v) ) 0.71. Analytical HPLC
analysis of RP-1 and SP-1 was performed on a Supelco Kromasil (Si-
100, 5 µm) column (4.6 mm × 250 mm) using a linear gradient of
EtOAc (1%/min) from 70% EtOAc in hexane at a flow rate of 2.0
mL/min. Under these conditions, the retention time tR of SP-1 and RP-1
on the column is 8.4 and 17.4 min, respectively. 31P NMR (121 MHz,
CD3CN) RP-1 δ 131.1 (d, JPF ) 135 Hz), 135.9; SP-1 δ (ppm) 128.8
(d, JPF ) 128 Hz), 132.6. 31P NMR (121 MHz, C6D6): RP-1 δ 127.0
(d, JPF ) 188 Hz), 134.0; SP-1 δ (ppm) 126.0 (d, JPF ) 182 Hz), 133.0.
Acknowledgment. This research was supported in part by
an appointment to the Postgraduate Research Participation
Program at the Center for Biologics Evaluation and Research
administered by the Oak Ridge Institute for Science and
Education through an interagency agreement between the U.S
Department of Energy and the U.S Food and Drug Administra-
tion.
Supporting Information Available: 1H and 13C NMR
spectra of 4 and 5.31P NMR spectra of RP-1, SP-1, 5, 6, 7, RP-
9, SP-9, RP-10, RP-11, SP-11, SP-12, and SP-14. 19F NMR spectra
of SP-1, 5, and 7. RP-HPLC Chromatograms of RP-13 and SP-
13, [RP, RP]- and [SP, SP]-d(CPSCPSC), P-diastereomeric
d(CPSCPSC), “trityl on” [RP]11-d[(TPS)11T], and PAGE profile
of “trityl off”[RP]11-d[(TPS)11T] (PDF). This material is available
19F NMR (282 MHz, C6D6) RP-1 δ -218.3 (dt, JFP ) 189 Hz, 2JFH
)
4
2
46.6 Hz), -227 (dt, JFP ) 3.8 Hz, JFH ) 46.6 Hz); SP-1 δ -218.5
(dt, JFP ) 181 Hz, 2JFH ) 46.6 Hz), -224.2 (dt, 4JFP ) 2.1 Hz, 2JFH
)
46.6 Hz). FAB-HRMS: RP-1: calcd for C47H44FN4O9P (M + Na+)
881.2728, found 881.2687; SP-1: calcd for C47H44FN4O9P (M + Na+)
881.2728, found 881.2653.
5′-O-(4,4′-Dimethoxytrityl)-3′-O-[3-(2-fluoroacetyl)-5-phenyl-1,3,2-
oxazaphospholanyl] thymidine (RP-14 and SP-14). The deoxyribo-
nucleoside cyclic N-acylphosphoramidites RP-14 and SP-14 were
prepared under conditions identical to those used for the synthesis of
RP-1 and SP-1 and were isolated in similar yields. 31P NMR (121 MHz,
C6D6) RP-14 δ 131.1 (d, JPF ) 135 Hz), 135.9; SP-14 δ (ppm) 128.9
(d, JPF ) 131 Hz), 133.2. FAB-HRMS: RP-14: calcd for C41H41FN3O9P
JA991773U
(36) This CPG support was prepared as reported in the literature; see:
Brown, T.; Pritchard, C. E.; Turner, G.; Salisbury, S. A. J. Chem. Soc.,
Chem. Commun. 1989, 891-893.
(37) Boal, J. H.; Wilk, A.; Harindranath, N.; Max, E. E.; Kempe, T.;
Beaucage, S. L. Nucleic Acids Res. 1996, 24, 3115-3117.